article · Clinical Nutrition
Micronutrient abnormalities, particularly low folate, selenium, and zinc, are prevalent in CYP undergoing cancer treatment, with folate showing the most consistent associations with treatment complications. This supports the need for routine monitoring; however, large international multicentre population-based and international mechanistic studies are warranted. PROSPERO Registration: Registration ID: CRD42025646467. Link: https://www.crd.york.ac.uk/PROSPERO/recorddashboard.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1016/j.clnu.2026.106653
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
